Nykode Therapeutics (NYKD)

Last close As at 27/02/2026

NOK2.89

−0.27 (−8.48%)

Market capitalisation

Nykode Therapeutics is an Oslo-based clinical-stage biopharmaceutical platform company dedicated to the discovery of novel immunotherapies. Nykode’s vision is to become a leading immunotherapy company, developing therapeutics across a range of areas with high unmet medical need, such as cancers and autoimmune diseases.

Latest Insights

Sector

Healthcare

Equity Analyst

Jyoti Prakash

Jyoti Prakash, CFA

Director, healthcare